Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of the clinical trial study, including the addition of specific cancer stages and the involvement of collaborators, while significant details about the trial's objectives and methodology have been removed.SummaryDifference55%
- Check30 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding two new dates: February 6, 2025, and February 28, 2025.SummaryDifference0.4%
- Check38 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and the removal of estimated dates for updates, providing more accurate information.SummaryDifference0.4%
- Check67 days agoChange DetectedThe web page has been updated to reflect new treatment protocols and results for colorectal cancer, including the addition of specific drugs and detailed treatment procedures. The timeline for results reporting has also been revised.SummaryDifference14%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.